A PHASE Ib, SINGLE- AND MULTIPLE-DOSE, OPEN-LABEL STUDY

Project: Research project

Description

A PHASE Ib, SINGLE- AND MULTIPLE-DOSE, OPEN-LABEL STUDY OF THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF OBINUTUZUMAB IN ADULTS WITH END-STAGE RENAL DISEASE AND HYPERSENSITIZATION AWAITING RENAL TRANSPLANTATION
StatusFinished
Effective start/end date7/15/155/31/18

Funding

  • Genentech Inc.

Fingerprint

Kidney Transplantation
Chronic Kidney Failure
Pharmacokinetics
Safety
obinutuzumab